Cargando…
Endoscopic duodenal mucosal resurfacing improves glycaemic and hepatic indices in type 2 diabetes: 6-month multicentre results
Insulin resistance is a core pathophysiological defect underscoring type 2 diabetes mellitus (T2DM) and non-alcoholic fatty liver disease (NAFLD). Both conditions improve with duodenal exclusion surgery. Duodenal mucosal resurfacing (DMR) is an endoscopic intervention developed to treat metabolic di...
Autores principales: | van Baar, Annieke C.G., Beuers, Ulrich, Wong, Kari, Haidry, Rehan, Costamagna, Guido, Hafedi, Alia, Deviere, Jacques, Ghosh, Soumitra S., Lopez-Talavera, Juan Carlos, Rodriguez, Leonardo, Galvao Neto, Manoel P., Sanyal, Arun, Bergman, Jacques J.G.H.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005649/ https://www.ncbi.nlm.nih.gov/pubmed/32039394 http://dx.doi.org/10.1016/j.jhepr.2019.10.006 |
Ejemplares similares
-
Duodenal mucosal resurfacing: Multicenter experience implementing a minimally invasive endoscopic procedure for treatment of type 2 diabetes mellitus
por: van Baar, Annieke C.G., et al.
Publicado: (2020) -
Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study
por: van Baar, Annieke C G, et al.
Publicado: (2020) -
Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: the randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trial
por: Mingrone, Geltrude, et al.
Publicado: (2022) -
Endoscopic duodenal mucosal resurfacing for nonalcoholic steatohepatitis (NASH): a pilot study
por: Hadefi, Alia, et al.
Publicado: (2021) -
OR30-07 Mixed Meal Tolerance Test (MMTT) Results from Revita-2, the First Randomized, Sham-Controlled, Double-Blind, Prospective, Multicenter Study of Duodenal Mucosal Resurfacing (DMR) Safety and Efficacy in Patients with Sub-Optimally Controlled Type 2 Diabetes (T2D)
por: Hopkins, David, et al.
Publicado: (2020)